Yandong
Xie
a,
Xueying
Lu
b,
Zhen
Wang
a,
Mingxi
Liu
a,
Liang
Liu
a,
Ran
Wang
a,
Kun
Yang
a,
Hong
Xiao
c,
Jianyong
Li
*b,
Xianglong
Tang
*ac and
Hongyi
Liu
*a
aDepartment of Neurosurgery, Affiliated Nanjing Brain Hospital, Nanjing Medical University, Nanjing 210029, China. E-mail: hyliu18@njmu.edu.cn; xltang0326@163.com
bDepartment of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University, Nanjing 210029, China. E-mail: lijianyonglm@126.com
cDepartment of Neuro-Psychiatric Institute, Affiliated Nanjing Brain Hospital, Nanjing Medical University, Nanjing 210029, China
First published on 20th May 2025
Removal of expression of concern for ‘A hypoxia-dissociable siRNA nanoplatform for synergistically enhanced chemo-radiotherapy of glioblastoma’ by Yandong Xie et al., Biomater. Sci., 2022, 10, 6791–6803, https://doi.org/10.1039/D2BM01145J.
Nanjing Brain Hospital has investigated the original experimental data and scientific records related to this article. They have confirmed that there is no evidence of fabrication or misconduct and that the data in Fig. 5 is accurate and the conclusions of this paper are valid.
This notice supersedes the information provided in the expression of concern related to this article.
Maria Southall
30th April 2025
Executive Editor, Biomaterials Science
This journal is © The Royal Society of Chemistry 2025 |